What Is Pancytopenia?
Panty topenia is a rare condition where the skin on your body becomes pale white or grayish. Some patients have no symptoms while others experience itchy rashes and other signs of infection. Other cases may not show any symptoms at all. It is usually seen in children under 5 years old but sometimes occurs in adults too. It affects both boys and girls, although they are affected differently due to different genetic makeup. It is very rare and is almost always fatal if left untreated.
The cause of pannyponynia remains unknown. There are several theories including:
A genetic predisposition
Genetic disorders such as albinism or sickle cell disease which affect pigmentation in general, causing pale skin in some individuals, but not others. This could explain why some people develop symptoms while others do not.
Certain medications such as antibiotics and steroids which can lead to temporary changes in pigmentation. These drugs are often prescribed for acne, eczema, psoriasis, and other conditions.
They may also be used to treat certain types of cancer. However, these drugs can cause permanent changes in pigmentation.
Environmental factors such as sun exposure or chemicals found in cosmetics which can affect pigmentation through the skin’s melanin production system (melanogenesis).
While the cause is unknown, most medical professionals advise that you should seek immediate medical treatment if you experience symptoms of pannyponynia. Don’t assume that it is a normal change in skin pigmentation due to a new medication or cosmetic.
Get a full physical examination to determine the cause and proper treatment options.
What Are The Symptoms Of Pancytopenia?
As mentioned above, the symptoms of pannyponynia vary from person to person. The most common are listed below:
Pale skin which can range from grayish-white through to a very fair and pale pink. In some cases the skin may also be slightly scaly or dark in patches.
Itchiness and rashes similar to eczema or psoriasis.
Eye problems such as dryness, redness, and sensitivity to light.
Mouth and throat ulcers.
Sores or blisters on the lips or nose.
Breathing problems such as wheezing, shortness of breath, and difficulty swallowing.
Poor weight gain and growth in children.
Diarrhea, nausea, and vomiting. These are fairly common symptoms in any case of leukemia.
Bone and joint pain which may be caused by a buildup of leukemia cells in the bones or leukemic infiltration where cancerous cells enter the bones from the bloodstream.
How Is Pannyponynia Treated?
Pannyponynia is most commonly treated using a combination of chemotherapy and radiation therapy. This is particularly the case for older patients, where a bone marrow transplant is often required as well. Treatments can range from several months to over a year and are fairly expensive.
While many cases of pannyponynia are effectively cured with treatment, it can also lead to other serious, life-threatening illnesses such as heart disease, certain types of cancer, liver failure, and infertility. Fortunately these instances are rare.
What Are The Prognosis And Long-Term Outlook For Pannyponynia?
The long-term outlook for pannyponnya is fairly good as most cases can be treated successfully. However, there is a risk of serious, life-threatening complications which can range from birth defects in future pregnancies to a high risk of developing leukemia again in the future.
In some cases, pannyponynia can return after many years. This is known as a relapse and most often occurs within the first 5 years after treatment.
It’s not fully understood why relapse occurs, but it is thought to be due to the development of resistant cancer stem cells (the cells responsible for growth and spread of the disease) during initial treatment.
What Is The Cause Of Pannyponynia?
The exact cause of pannyponynia is not yet fully understood. It’s thought to be down to a combination of genetic and environmental factors.
Those with a family history of the disease are at a higher risk of developing it and it appears to occur more often in males than females. Radiation exposure and certain viral infections have both been suggested as possible risk factors, but further studies are required to confirm this.
Sources & references used in this article:
Pancytopenia–a six year study. by R Kumar, SP Kalra, H Kumar, AC Anand… – The Journal of the …, 2001 – europepmc.org
Bone marrow examination in cases of pancytopenia by A Jha, G Sayami, RC Adhikari… – J Nepal Med …, 2008 – pdfs.semanticscholar.org
Pancytopenia–a clinico haematological study of 200 cases. by JM Khunger, S Arulselvi, U Sharma… – Indian journal of …, 2002 – ncbi.nlm.nih.gov
Patterns of pancytopenia patients in a general medical ward and a proposed diagnostic approach by O Ishtiaq, HZ Baqai, F Anwer… – Journal of Ayub Medical …, 2004 – jamc.ayubmed.edu.pk
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis by S Gutierrez‐Ureña, JF Molina… – … : Official Journal of …, 1996 – Wiley Online Library
Pancytopenia: a clinico hematological study by BN Gayathri, KS Rao – Journal of laboratory physicians, 2011 – ncbi.nlm.nih.gov
Pancytopenia in Zimbabwe by B Mudenge, DG Savage, RH Allen… – The American journal of …, 1999 – Elsevier
Pancytopenia–a clinico-hematologic analysis of 77 cases. by V Tilak, R Jain – Indian journal of pathology & microbiology, 1999 – europepmc.org